Current role
Sandra L. Silberman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
CNS Pharmaceuticals, Inc. (CNSP)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CNS Pharmaceuticals, Inc. (CNSP) | Former Chief Medical Officer | $495,000 | $720,818 |
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Former Chief Medical Officer | $200,000 | $361,641 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $270,152 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $281,306 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $269,238 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $175,000 | $340,958 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $23,333 | $272,721 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.